studi
investig
role
mechan
alprostadil
acut
respiratori
distress
syndrom
ard
induc
oleic
acid
oa
rat
spraguedawley
rat
randomli
divid
control
oa
model
oa
alprostadil
respect
group
ard
model
induc
femor
vein
inject
oa
alprostadil
administr
immedi
lung
injuri
evalu
lung
wetdri
weight
ratio
wd
histolog
analys
express
ace
inflammatori
mediat
apoptoticrel
protein
protein
mapk
nfkb
signal
pathway
determin
western
blot
immunohistochem
stain
compar
control
group
oa
model
group
significantli
increas
wd
lung
injuri
score
collagen
deposit
h
oa
inject
howev
alprostadil
treatment
significantli
reduc
oainduc
elev
indic
addit
oainduc
express
tnfa
suppress
alprostadil
oainduc
activ
nuclear
factor
nf
kb
also
reduc
alprostadil
furthermor
found
alprostadil
inhibitori
effect
phosphoryl
jnk
mapk
alprostadil
inhibit
bax
increas
indic
suppress
role
apoptosi
remark
increas
express
ace
oa
model
group
observ
decreas
alprostadil
alprostadil
protect
effect
ard
induc
oa
rat
possibl
inhibit
apoptosi
suppress
activ
mapk
nfkb
signal
pathway
decreas
ace
protein
express
therefor
use
alprostadil
clinic
ard
treatment
promis
background
acut
respiratori
distress
syndrom
ard
also
known
acut
lung
injuri
ali
one
challeng
clinic
condit
critic
care
medicin
sever
lifethreaten
medic
condit
character
acut
widespread
inflamm
lung
lead
proteinrich
nonhydrostat
pulmonari
edema
refractori
hypoxemia
increas
lung
stiff
impair
abil
lung
remov
carbon
dioxid
mani
pathogen
condit
trigger
ard
sepsi
pneumonia
although
outcom
ard
improv
advanc
ventil
strategi
mortal
still
high
lung
safe
studi
report
hospit
mortal
rate
signific
increas
across
ard
sever
categori
line
berlin
definit
mild
ard
moder
ard
sever
ard
specif
effect
pharmacolog
intervent
ard
current
avail
therefor
critic
develop
new
clinic
drug
treatment
ard
alprostadil
lipid
microsphereincorpor
prostaglandin
report
promot
pulmonari
vasodil
also
antiinflammatori
antiplatelet
aggreg
properti
metaanalysi
demonstr
inhal
prostaglandin
could
reduc
pulmonari
arteri
pressur
increas
oxygen
prostaglandin
also
report
decreas
lung
vascular
permeabl
addit
hasegawa
et
al
report
prostaglandin
improv
microcircul
thu
alprostadil
may
use
prevent
treatment
ard
howev
underli
mechan
alprostadil
prevent
ard
remain
unknown
recent
studi
show
activ
mitogenactiv
protein
kinas
mapk
pathway
involv
ard
phosphoryl
level
mapk
extracellular
signalregul
kinas
erk
jun
ntermin
kinas
jnk
significantli
increas
lpsinduc
lung
injuri
consequ
inhibit
protein
effici
attenu
lpsinduc
pulmonari
inflammatori
respons
addit
possibl
mechan
oleic
acid
oa
induc
acut
lung
injuri
ali
ard
rat
oa
activ
nfkb
signal
pathway
increas
express
mani
proinflammatori
cytokin
includ
tnfa
therefor
hypothes
alprostadil
protect
oainduc
ard
inhibit
mapk
nfkb
pathway
reninangiotensin
system
ra
play
key
role
maintain
blood
pressur
homeostasi
well
fluid
salt
balanc
mani
year
angiotensinconvert
enzym
ace
known
key
enzym
regul
ra
pulmonari
circul
import
target
reninangiotensin
system
lung
ace
activ
trigger
vasoconstrict
gener
angiotensin
ii
angiotensin
previou
report
indic
ra
play
critic
role
ard
instanc
angiotensin
ii
ang
ii
receptor
induc
pulmonari
vasoconstrict
suggest
vital
role
ang
ii
elev
pulmonari
vascular
tone
caus
pulmonari
edema
addit
accumul
data
suggest
ang
ii
also
increas
vascular
permeabl
via
sever
mediat
implic
ang
iiregul
vascular
permeabl
chang
includ
eicosanoid
leukotrien
prostaglandin
prostaglandin
vascular
permeabl
factor
therefor
ace
function
lunginjurypromot
factor
ali
need
control
treatment
prevent
ard
dysregul
apoptosi
pathway
result
epitheli
injuri
characterist
ali
famili
includ
antiapoptot
gene
proapoptot
gene
bax
also
close
associ
apoptosi
sensit
apoptot
signal
mainli
depend
process
competit
dimer
cell
express
high
level
homodim
heterodim
creat
dna
cleavag
activ
endonucleas
inhibit
suppress
apoptosi
bax
overexpress
baxbax
homodim
form
acceler
apoptosi
final
demonstr
ratio
bax
crucial
index
process
apoptosi
indic
sever
apoptosi
strategi
block
apoptosi
pathway
could
effect
limit
ali
oleic
acid
oa
fatti
acid
deriv
anim
plant
oil
administ
intraven
oa
induc
acut
diffus
lung
injuri
similar
initi
phase
ali
ard
human
follow
oa
administr
pulmonari
vascular
endotheli
cell
injuri
local
hemorrhag
edema
inflamm
occur
thu
use
oa
mimic
ard
anim
model
well
establish
studi
oainduc
ard
model
use
investig
effect
alprostadil
lung
injuri
moreov
possibl
mechan
involv
alprostadil
role
ard
also
examin
mapk
nfkb
pathway
ace
express
apoptosi
studi
thu
may
provid
experiment
evid
clinic
use
alprostadil
treatment
ard
thirti
male
spraguedawley
rat
g
weight
week
age
purchas
anim
center
yanbian
univers
jilin
china
licens
scxk
jilin
anim
hous
lightdark
cycl
free
access
food
water
experiment
protocol
approv
anim
care
committe
ethic
committe
anim
research
yanbian
univers
procedur
perform
strictli
accord
nation
institut
health
guid
care
use
laboratori
anim
rat
randomli
divid
group
control
oa
bai
hui
biolog
technolog
co
ltd
shenyang
china
model
oa
alprostadil
oa
alprostadil
oa
alprostadil
group
dose
alprostadil
determin
accord
previou
report
rat
anesthet
urethan
bai
hui
biolog
technolog
co
ltd
dose
gkg
dose
mlkg
oa
equal
amount
salin
inject
slowli
femor
vein
induc
ard
rat
control
group
administ
equal
volum
salin
immedi
oa
administr
alprostadil
inject
beij
tide
pharmaceut
co
ltd
china
nation
medicin
permiss
number
dose
equal
amount
salin
given
administ
rat
oa
alprostadil
oa
alprostadil
oa
alprostadil
group
respect
femor
vein
inject
three
hour
oa
administr
anim
sacrif
lung
excis
wet
weight
middl
lobe
right
lung
determin
immedi
remov
dri
oven
h
dri
weight
right
lung
measur
lung
wd
ratio
calcul
left
lung
tissu
sampl
fix
buffer
formalin
h
dehydr
grade
ethanol
sampl
embed
paraffin
cut
section
section
stain
hematoxylin
eosin
accord
routin
procedur
observ
light
microscop
vanox
olympu
japan
lung
injuri
score
evalu
base
follow
alveolar
congest
b
hemorrhag
c
infiltr
aggreg
neutrophil
airspac
vessel
wall
thick
alveolar
wallhyalin
membran
format
item
score
scale
follow
minim
damag
mild
damag
moder
damag
sever
damag
maxim
damag
fibrosi
evalu
use
masson
trichromestain
section
section
observ
magnif
microscop
vanox
olympu
japan
blue
signal
indic
posit
stain
collagen
extent
fibrosi
section
grade
use
follow
criteria
none
evid
fibrosi
mild
focal
region
fibrosi
involv
less
lung
fibrosi
involv
pleura
interstitium
subpleur
parenchyma
distort
alveolar
architectur
moder
extens
fibrosi
involv
lung
fibrot
region
mostli
extend
inward
pleura
still
focal
sever
widespread
fibrosi
involv
lung
confluent
lesion
extens
derang
parenchym
architectur
includ
cystic
air
space
line
cuboid
epithelium
lung
section
kept
oven
h
increas
section
adher
slide
deparaffin
rehydr
section
treat
mm
citrat
buffer
cat
zsgbbio
beij
china
min
antigen
retriev
section
incub
h
min
elimin
endogen
peroxidas
activ
follow
wash
time
pb
tb
min
time
section
wash
pb
time
min
time
ad
rabbit
antirat
antiac
antibodi
dilut
elabsci
biotechnolog
co
ltd
china
follow
incub
overnight
section
wash
time
pb
tb
min
time
ad
reagent
incub
section
room
temperatur
min
follow
wash
time
pb
min
time
reagent
ad
follow
incub
room
temperatur
min
wash
time
pb
min
time
color
develop
perform
dab
cat
zsgbbio
beij
china
wash
section
deioniz
water
make
section
counterstain
dewat
transpar
seal
section
view
microscop
magnif
differ
microscop
field
randomli
chosen
quantit
analysi
ace
express
perform
calcul
averag
optic
densiti
aceposit
stain
total
protein
isol
rest
right
lung
tissu
homogen
protein
concentr
determin
use
bca
protein
assay
kit
beyotim
china
equal
quantiti
protein
sampl
separ
sdspage
transfer
pvdf
membran
membran
block
skim
milk
incub
antiac
antitnfa
antibax
antinfkb
antipjnk
antijnk
antibactin
antibodi
overnight
goat
antirabbit
mous
secondari
antibodi
conjug
horseradish
peroxidas
ad
secondari
antibodi
antibodi
use
purchas
elabsci
biotechnolog
co
ltd
china
immunodetect
carri
ecl
detect
reagent
beyotim
china
bactin
use
load
control
result
protein
express
western
blot
express
ratio
optic
densiti
valu
target
band
intern
control
use
quantiti
one
softwar
biorad
technic
servic
depart
statist
analysi
spss
softwar
use
statist
analysi
data
present
mean
statist
signific
differ
assess
use
oneway
anova
valu
p
consid
statist
signific
examin
effect
alprostadil
oainduc
ard
first
investig
wd
ratio
lung
rat
wd
ratio
lung
tissu
repres
lung
water
content
use
indic
lung
edema
shown
figur
wd
ratio
oa
model
group
significantli
increas
p
compar
control
group
howev
alprostadil
treatment
decreas
oainduc
wd
ratio
compar
oa
model
group
statist
signific
observ
alprostadil
administr
p
result
suggest
alprostadil
protect
effect
oainduc
lung
edema
alprostadil
amelior
oainduc
lung
tissu
histopatholog
chang
next
investig
effect
alprostadil
histopatholog
chang
lung
h
e
stain
structur
alveoli
complet
obviou
patholog
chang
control
group
figur
oa
challeng
caus
signific
patholog
chang
includ
infiltr
inflammatori
cell
aggreg
neutrophil
alveolu
alveolar
fluid
thicken
alveolar
wall
pulmonari
congest
figur
alprostadil
treatment
amelior
tissu
damag
dosedepend
manner
importantli
oa
alprostadil
group
damag
structur
alveoli
obvious
restor
compar
oa
model
group
moreov
lung
injuri
score
figur
oa
model
group
significantli
increas
compar
control
group
contrast
compar
oa
model
group
alprostadil
significantli
decreas
lung
injuri
score
similar
result
obtain
masson
trichrom
stain
shown
figur
collagen
deposit
higher
fibrosi
score
observ
oa
model
group
compar
control
group
alprostadil
treatment
reduc
collagen
deposit
fibrosi
score
dosedepend
manner
data
suggest
alprostadil
protect
rat
oainduc
lung
tissu
damag
effect
alprostadil
product
proinflammatori
mediat
tnfa
also
analyz
western
blot
h
administr
oa
oa
administr
caus
signific
increas
tnfa
express
lung
tissu
compar
control
group
figur
p
alprostadil
administr
caus
obvious
decreas
express
tnfa
lung
tissu
compar
oa
model
group
result
indic
alprostadil
inhibit
product
proinflammatori
mediat
protect
rat
oainduc
lung
inflamm
alprostadil
suppress
mapk
nfkb
signal
pathway
oainduc
ard
rat
nfkb
mapk
signal
pathway
play
key
role
oainduc
ard
pathogenesi
therefor
investig
whether
alprostadil
could
affect
pathway
western
blot
analysi
show
phosphoryl
mapk
significantli
upregul
oa
includ
mapk
figur
figur
pjnk
figur
moreov
oa
administr
markedli
increas
phosphoryl
figur
condit
confirm
serum
ace
activ
significantli
elev
activ
ard
patient
measur
serum
ace
activ
use
follow
clinic
cours
diseas
sever
studi
suggest
monitor
serum
ace
use
indic
endotheli
cell
integr
stain
result
show
express
ace
protein
lung
tissu
oa
model
group
obvious
higher
control
group
figur
suggest
ace
involv
develop
ard
contrast
oa
alprostadil
group
express
ace
partial
reduc
compar
oa
model
group
figur
effect
alprostadil
ace
product
also
analyz
western
blot
oa
administr
caus
signific
increas
ace
express
lung
tissu
compar
control
group
figur
p
expect
alprostadil
prevent
increas
ace
oainduc
ard
rat
dosedepend
manner
signific
differ
found
alprostadil
administr
figur
result
suggest
alprostadil
inhibit
product
ace
lung
tissu
oainduc
ard
rat
studi
demonstr
oa
administr
evok
sever
lung
injuri
character
increas
inflammatori
cell
infiltr
edema
hemorrhag
interstitium
alveolu
well
collagen
deposit
addit
oa
administr
significantli
increas
lung
wd
ration
express
ace
proinflammatori
factor
proapoptot
protein
activ
mapk
nfkb
signal
pathway
rat
lung
tissu
importantli
alprostadil
treatment
significantli
attenu
oainduc
ard
symptom
well
suppress
elev
ardsrel
protein
activ
mapk
nfkb
pathway
taken
togeth
find
suggest
alprostadil
administr
prevent
oainduc
ard
inflamm
may
use
therapeut
agent
ard
treatment
alprostadil
extens
use
clinic
treatment
multiplesystem
diseas
howev
therapeut
effect
alprostadil
ard
remain
unclear
report
alprostadil
exert
effect
protect
pulmonari
vascular
endotheli
cell
howev
oainduc
ard
model
featur
injuri
pulmonari
vascular
endotheli
cell
thu
present
studi
oainduc
ard
model
use
investig
role
alprostadil
ard
lung
wd
ratio
cytokin
level
h
e
masson
trichrom
stain
lung
tissu
evalu
wd
ratio
consid
indic
lung
edema
oa
report
abl
augment
edema
format
cytokin
product
bronchoalveolar
fluid
swiss
webster
mice
tnfa
known
proinflammatori
cytokin
stimul
product
cytokin
product
report
significantli
increas
aliard
patient
masson
trichrom
stain
perform
observ
collagen
format
bronchial
airway
result
show
typic
patholog
chang
lung
oaadministr
rat
mark
alveolar
fluid
thicken
alveolar
wall
lung
alveolar
wall
disrupt
leukocyt
infiltr
collagen
deposit
lung
express
tnfa
lung
tissu
significantli
increas
wd
ratio
increas
ard
rat
oa
alprostadil
group
show
clearli
reduc
lung
damag
wd
ratio
rat
lung
tissu
product
tnfa
well
collagen
format
compar
oa
model
group
data
indic
protect
role
alprostadil
ard
nfkb
implic
regul
inflammatori
immun
respons
play
import
role
develop
ard
mapk
also
critic
role
regul
cell
growth
differenti
control
cellular
respons
cytokin
stress
nfkb
mapk
signal
pathway
activ
oa
regul
releas
proinflammatori
cytokin
tnfa
recent
studi
suggest
alprostadil
reduc
lpsinduc
ali
downregul
nfkb
activ
inhibit
express
harm
inflammatori
cytokin
result
show
oa
administr
markedli
increas
phosphoryl
nfkb
mapk
includ
mapk
jnk
howev
alprostadil
complet
revers
increas
activ
mapk
nfkb
signal
pathway
induc
oa
thu
demonstr
alprostadil
protect
oainduc
ard
inhibit
mapk
nfkb
signal
pathway
addit
recent
studi
shown
apoptosi
crucial
mechan
develop
ard
balanc
proapoptot
antiapoptot
factor
lung
may
play
import
role
determin
fate
epithelium
famili
includ
antiapoptot
gene
proapoptot
gene
bax
also
close
associ
apoptosi
sensit
apoptot
signal
mainli
depend
process
competit
dimer
cell
express
high
level
homodim
heterodim
creat
dna
cleavag
activ
endonucleas
inhibit
suppress
apoptosi
bax
overexpress
baxbax
homodim
form
acceler
apoptosi
final
demonstr
ratio
bax
crucial
index
process
apoptosi
indic
sever
apoptosi
effect
alprostadil
regul
bax
previous
report
confirm
find
western
blot
analysi
use
detect
protein
express
level
bax
studi
signific
apoptosi
seen
oa
model
group
lung
tissu
alprostadil
downregul
protein
express
level
bax
upregul
express
level
lung
tissu
caus
decreas
rate
lung
tissu
apoptosi
oaalprostadil
group
support
alprostadil
protect
lung
injuri
oainduc
ard
recent
decad
ra
thought
essenti
maintain
blood
pressur
homeostasi
well
fluid
salt
balanc
latest
evid
suggest
activ
pulmonari
ra
influenc
pathogenesi
ard
via
mechan
inflamm
vascular
permeabl
vascular
tone
fibroblast
activ
ace
key
member
classic
reninangiotensin
system
lung
major
organ
express
ace
human
rat
import
ra
ard
wide
emphas
idel
et
al
found
ard
patient
elev
ace
level
bronchoalveolar
lavag
orfano
also
report
pulmonari
capillari
endotheliumbound
ace
activ
correl
sever
lung
injuri
patient
acut
respiratori
distress
syndrom
present
studi
use
western
blot
immunohistochemistri
examin
express
ace
lunginjurypromot
factor
ali
lung
tissu
assess
degre
lung
injuri
found
oa
administr
caus
signific
increas
express
ace
lung
tissu
compar
control
group
suggest
ace
ard
signific
correl
could
specul
inject
oa
aggrav
lung
injuri
unceasingli
increas
ace
lung
would
increas
ra
activ
lung
ace
may
caus
pulmonari
vasoconstrict
pulmonari
arteri
pressur
upgrad
well
increas
pneumoangiogram
permeabl
via
increas
ra
activ
addit
ace
may
promot
infiltr
monocytesmacrophag
promot
inflammatori
factor
secret
lead
sever
lung
injuri
format
pulmonari
hypertens
fibrosi
howev
upregul
ace
express
significantli
revers
alprostadil
treatment
result
suggest
lung
ra
particip
injuri
process
alprostadil
protect
effect
lung
injuri
oainduc
ard
protect
effect
might
relat
abil
prevent
releas
proinflammatori
mediat
suppress
activ
mapk
nfkb
signal
pathway
downregul
ace
express
inhibit
lung
cell
apoptosi
data
thu
suggest
alprostadil
promis
drug
use
treatment
ard
